Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS).
Clinical trial NCT05947617 · UNKNOWN
Trial details
- NCT number
- NCT05947617
- Sponsor
- Neobiosis, LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2025-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.